{
    "title": "J&J multiple myeloma drug succeeds in first-line combination study",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-5104051/J-J-multiple-myeloma-drug-succeeds-line-combination-study.html",
    "date": "2017-11-21",
    "keywords": [
        "percent",
        "therapy",
        "combination",
        "group",
        "rate",
        "darzalex",
        "response",
        "bill",
        "berkrot",
        "drug",
        "progression",
        "blood",
        "cancer",
        "approval",
        "myeloma",
        "daratumumab",
        "firstline",
        "bone",
        "marrow",
        "ash",
        "versus",
        "risk",
        "disease",
        "death",
        "opportunity",
        "medicine",
        "jampjs",
        "growth",
        "treatment",
        "quarter",
        "thomson",
        "study",
        "transplant",
        "chemotherapy",
        "melphalan",
        "prednisone",
        "time",
        "survival",
        "summary",
        "month",
        "society",
        "hematology",
        "meeting",
        "atlanta",
        "pfs",
        "control",
        "data",
        "vs",
        "dr",
        "president",
        "trial",
        "europe",
        "corps",
        "revlimid",
        "part",
        "basis",
        "anderson",
        "reporting",
        "andrew",
        "hay"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}